Clinical services

Services Portfolio

Utilising the latest technologies to deliver molecular diagnostics and genomic services NewGene is able to offer significant benefits that can lead to improved clinical delivery:

  • Turnaround: Clinically relevant turnaround times
  • Response: Emerging clinical need can be met with rapid development of new tests
  • Savings: The high throughput capacity of the technology gives rise to savings in both time and cost
  • Quality: An excellent track record in external quality assessment
  • Flexibility: NewGene can develop a bespoke service to meet your specific needs.

Any mutations found that are of pathological significance in all NewGene clinical tests are reported by an HCPC registered Clinical Scientist.

NewGene also works closely with the NHS and pharmaceutical companies on the validation of biomarkers and the development of diagnostic tests for personalised medicine to ensure access to leading clinical services.

development of diagnostic tests for personalised medicine ensures access to leading clinical services

NewGene Ltd

Bioscience Building, International Centre for Life, Newcastle upon Tyne, NE1 4EP, UK
Tel: +44 (0)191 242 1923 | Fax: +44 (0)191 241 8799 | Email: info@newgene.org.uk | Web:www.newgene.org.uk

NewGene Limited | Company Number: 06735445

NewGene partners